ICUI
Income statement / Annual
Last year (2024), ICU Medical, Inc.'s total revenue was $2.38 B,
an increase of 5.44% from the previous year.
In 2024, ICU Medical, Inc.'s net income was -$117.69 M.
See ICU Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.38 B |
$2.26 B |
$2.28 B |
$1.32 B |
$1.27 B |
$1.27 B |
$1.40 B |
$1.29 B |
$379.37 M |
$341.67 M |
| Cost of Revenue |
$1.56 B
|
$1.52 B
|
$1.58 B
|
$824.82 M
|
$809.51 M
|
$794.34 M
|
$830.01 M
|
$866.52 M
|
$177.97 M
|
$160.87 M
|
| Gross Profit |
$824.78 M
|
$739.87 M
|
$697.76 M
|
$491.49 M
|
$461.50 M
|
$471.86 M
|
$570.03 M
|
$426.10 M
|
$201.40 M
|
$180.80 M
|
| Gross Profit Ratio |
0.35
|
0.33
|
0.31
|
0.37
|
0.36
|
0.37
|
0.41
|
0.33
|
0.53
|
0.53
|
| Research and Development Expenses |
$88.62 M
|
$85.34 M
|
$92.98 M
|
$47.50 M
|
$42.95 M
|
$48.61 M
|
$52.87 M
|
$51.25 M
|
$12.96 M
|
$15.71 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$276.88 M
|
$328.15 M
|
$303.95 M
|
$89.43 M
|
$1.80 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$100,000.00
|
$600,000.00
|
$200,000.00
|
$100,000.00
|
$81.42 M
|
| Selling, General & Administrative Expenses |
$638.76 M
|
$606.69 M
|
$608.35 M
|
$302.58 M
|
$283.95 M
|
$276.98 M
|
$328.15 M
|
$303.95 M
|
$89.43 M
|
$83.22 M
|
| Other Expenses |
$54.44 M
|
$25.01 M
|
-$5.14 M
|
$127,000.00
|
-$975,000.00
|
$5.74 M
|
$1.47 M
|
-$2.48 M
|
$767,000.00
|
$1.13 M
|
| Operating Expenses |
$781.82 M
|
$717.05 M
|
$701.33 M
|
$350.21 M
|
$325.93 M
|
$331.33 M
|
$381.01 M
|
$355.21 M
|
$102.38 M
|
$98.93 M
|
| Cost And Expenses |
$2.34 B
|
$2.24 B
|
$2.28 B
|
$1.18 B
|
$1.14 B
|
$1.13 B
|
$1.21 B
|
$1.22 B
|
$280.36 M
|
$259.80 M
|
| Interest Income |
$10.79 M
|
$7.51 M
|
$4.43 M
|
$2.80 M
|
$3.70 M
|
$6.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$106.54 M
|
$102.73 M
|
$66.38 M
|
$858,000.00
|
$1.75 M
|
$549,000.00
|
$709,000.00
|
$2.05 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$228.77 M
|
$258.80 M
|
$99.29 M
|
$94.85 M
|
$85.21 M
|
$74.74 M
|
$66.57 M
|
$19.05 M
|
$18.07 M
|
| EBITDA |
$42.96 M |
$253.20 M |
$191.55 M |
$223.46 M |
$194.09 M |
$200.47 M |
$271.89 M |
$205.54 M |
$118.07 M |
$99.94 M |
| EBITDA Ratio |
0.02
|
0.11
|
0.1
|
0.11
|
0.11
|
0.12
|
0.14
|
0.05
|
0.35
|
0.33
|
| Operating Income Ratio |
0.02
|
0.01
|
-0
|
0.04
|
0.03
|
0.05
|
0.02
|
-0.01
|
0.22
|
0.2
|
| Total Other Income/Expenses Net |
-$108.98 M
|
-$101.12 M
|
-$71.51 M
|
-$59,000.00
|
-$668,000.00
|
$7.35 M
|
-$7.38 M
|
$64.58 M
|
$2.22 M
|
$1.13 M
|
| Income Before Tax |
-$66.01 M
|
-$78.30 M
|
-$114.41 M
|
$123.19 M
|
$97.49 M
|
$114.71 M
|
$22.37 M
|
$51.28 M
|
$85.16 M
|
$69.70 M
|
| Income Before Tax Ratio |
-0.03
|
-0.03
|
-0.05
|
0.09
|
0.08
|
0.09
|
0.02
|
0.04
|
0.22
|
0.2
|
| Income Tax Expense |
$51.68 M
|
-$48.64 M
|
-$40.12 M
|
$20.05 M
|
$10.62 M
|
$13.67 M
|
-$6.42 M
|
-$17.36 M
|
$22.08 M
|
$24.71 M
|
| Net Income |
-$117.69 M
|
-$29.66 M
|
-$74.29 M
|
$103.14 M
|
$86.87 M
|
$101.04 M
|
$28.79 M
|
$68.64 M
|
$63.08 M
|
$44.99 M
|
| Net Income Ratio |
-0.05
|
-0.01
|
-0.03
|
0.08
|
0.07
|
0.08
|
0.02
|
0.05
|
0.17
|
0.13
|
| EPS |
-4.83 |
-1.23 |
-3.11 |
4.86 |
4.16 |
4.9 |
1.33 |
3.5 |
3.9 |
2.84 |
| EPS Diluted |
-4.83 |
-1.23 |
-3.11 |
4.74 |
4.02 |
4.69 |
1.33 |
3.29 |
3.66 |
2.73 |
| Weighted Average Shares Out |
$24.39 M
|
$24.09 M
|
$23.87 M
|
$21.21 M
|
$20.91 M
|
$20.63 M
|
$21.60 M
|
$19.61 M
|
$16.17 M
|
$15.85 M
|
| Weighted Average Shares Out Diluted |
$24.39 M
|
$24.09 M
|
$23.87 M
|
$21.78 M
|
$21.59 M
|
$21.55 M
|
$21.60 M
|
$20.86 M
|
$17.25 M
|
$16.50 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
